DESMOPRESSIN ORAL LYOPHILISATE (Noqdirna ®)

Clinical Indication

Symptomatic treatment of nocturia due to idiopathic nocturnal polyuria in adults

Comments

To be started in primary care only. Please click drug name for more information.

Local guidance

Expert opinion in UHL is that all patients should have U+ E checked beforehand and monitored afterwards. NICE and the manufacturer provides extra monitoring requirements for those 65 years and over. Please note doses are lower for women due to increased risk of hyponatraemia.

Date of classification

February 2019

Green

Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.